Quantification of new intracerebral lesions on diffusion-weighted magnetic resonance imaging after transcarotid artery revascularization for treatment of carotid artery stenosis

被引:1
作者
Balceniuk, Mark D. [1 ]
Gonring, Dakota [1 ]
Wang, Maxwell [1 ]
Westfall, Cynthia [1 ]
Portanova, Anthony [2 ]
Stoner, Michael C. [1 ]
Mix, Doran S. [2 ,3 ]
机构
[1] Univ Rochester, Dept Surg, Div Vasc Surg, Rochester, NY 14620 USA
[2] Univ Rochester, Dept Imaging Sci, Div Neuroradiol, Rochester, NY 14620 USA
[3] Univ Rochester, Dept Vasc Surg, 601 Elmwood Ave, Rochester, NY 14620 USA
来源
JOURNAL OF VASCULAR SURGERY CASES INNOVATIONS AND TECHNIQUES | 2023年 / 9卷 / 01期
关键词
2023; 9; ) TCAR; MRI; Carotid stenosis; Carotid stent; Flow reversal; ANTIPLATELET THERAPY; ENDARTERECTOMY;
D O I
10.1016/j.jvscit.2023.101102
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Transcarotid artery revascularization (TCAR) has been used with increasing prevalence for treatment of carotid artery stenosis. TCAR holds potential benefits over traditional carotid endarterectomy (CEA) or transfemoral carotid artery stenting by its nature of being less invasive than CEA but more neuroprotective than transfemoral carotid artery stenting. The purpose of this pilot study is to evaluate the effectiveness of the neuroprotection system of TCAR with flow reversal by quantifying the incidence and degree of new intracerebral lesions using diffusion-weighted magnetic resonance im-aging (DW-MRI). This study is the first to evaluate these findings in a real-world, high-risk cohort, who would have been excluded from the ROADSTER and ENROUTE transcarotid neuroprotection system DW-MRI studies. Methods: Patients undergoing unilateral TCAR for symptomatic or asymptomatic severe internal carotid artery disease were eligible and prospectively enrolled in the study. All patients had high risk features, including comorbidities or medications, which excluded them from industry-sponsored DW-MRI trials. Patients underwent a preoperative DW-MRI to obtain a baseline intracerebral evaluation within 1 week of the scheduled surgery. The follow-up DW-MRI occurred within 48 hours postoperatively. The primary outcome was new, acute postoperative lesion(s) identified on DW-MRI. Secondary outcomes include any major stroke, myocardial infarction, or death during hospitalization. Results: Five consecutive patients underwent TCAR with preoperative and postoperative imaging. All five patients were on dual antiplatelet therapy before their procedure and verified to be therapeutic on these agents. All patients under-went a right-sided TCAR and three were symptomatic as the indication for their procedure. All five patients demon-strated chronic lesions on the preoperative DW-MRI. Technical success was achieved in all five patients, with one operative complication involving a dissection of the common carotid at the access site, which was stented using the TCAR system. Postoperative DW-MRI did not identify any new intracerebral lesions in any patient following the pro-cedure. No patient had a stroke, myocardial infarction, or death during hospitalization. Conclusions: In this real-world, high-risk cohort, TCAR was completed with no evidence of new, postoperative DW-MRI lesions. These data further demonstrate that TCAR with flow reversal is an effective neuroprotective strategy for carotid revascularization. Further study is warranted to evaluate DW-MRI differences between TCAR and CEA. (J Vasc Surg Cases Innov Tech 2023;9:1-6.)
引用
收藏
页数:6
相关论文
共 14 条
  • [1] Bonati LH, 2010, LANCET NEUROL, V9, P353, DOI 10.1016/S1474-4422(10)70057-0
  • [2] Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
    Brott, Thomas G.
    Hobson, Robert W., II
    Howard, George
    Roubin, Gary S.
    Clark, Wayne M.
    Brooks, William
    Mackey, Ariane
    Hill, Michael D.
    Leimgruber, Pierre P.
    Sheffet, Alice J.
    Howard, Virginia J.
    Moore, Wesley S.
    Voeks, Jenifer H.
    Hopkins, L. Nelson
    Cutlip, Donald E.
    Cohen, David J.
    Popma, Jeffrey J.
    Ferguson, Robert D.
    Cohen, Stanley N.
    Blackshear, Joseph L.
    Silver, Frank L.
    Mohr, J. P.
    Lal, Brajesh K.
    Meschia, James F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) : 11 - 23
  • [3] The role of antiplatelet therapy in carotid stenting for ischemic stroke prevention
    Chaturvedi, Seemant
    Yadav, Jay S.
    [J]. STROKE, 2006, 37 (06) : 1572 - 1577
  • [4] Outcomes and strategy of tailored antiplatelet therapy with ticagrelor in patients undergoing transcarotid artery revascularization
    Ghamraoui, Ahmed K.
    Ricotta, Joseph J., II
    [J]. JOURNAL OF VASCULAR SURGERY, 2021, 73 (01) : 132 - 141
  • [5] One-year outcomes after transcarotid artery revascularization (TCAR) in the ROADSTER 2 trial
    Kashyap, Vikram S.
    So, Kristine L.
    Schneider, Peter A.
    Rathore, Rama
    Thi Pham
    Motaganahalli, Raghu L.
    Massop, Douglas W.
    Foteh, Mazin I.
    Eckstein, Hans-Henning
    Jim, Jeffrey
    Lorenzo, Jose Ignacio Leal
    Melton, James G.
    [J]. JOURNAL OF VASCULAR SURGERY, 2022, 76 (02) : 466 - +
  • [6] Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients With Significant Carotid Artery Disease
    Kashyap, Vikram S.
    Schneider, Peter A.
    Foteh, Mazin
    Motaganahalli, Raghu
    Shah, Rasesh
    Eckstein, Hans-Henning
    Henao, Steve
    LaMuraglia, Glenn
    Stoner, Michael C.
    Melton, Jim
    Massop, Douglas
    Hanover, Tod
    Titus, Jessica
    Moore, Wesley S.
    Rodriguez-Carvajal, Ruben
    Malas, Mahmoud B.
    Arko, Frank R., III
    Pierce, Damon
    Anain, Paul
    Oskin, Timothy
    [J]. STROKE, 2020, 51 (09) : 2620 - 2629
  • [7] Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal
    Kwolek, Christopher J.
    Jaff, Michael R.
    Leal, J. Ignacio
    Hopkins, L. Nelson
    Shah, Rasesh M.
    Hanover, Todd M.
    Macdonald, Sumaira
    Cambria, Richard P.
    [J]. JOURNAL OF VASCULAR SURGERY, 2015, 62 (05) : 1227 - +
  • [8] Transcarotid artery revascularization versus transfemoral carotid artery stenting in the Society for Vascular Surgery Vascular Quality Initiative
    Malas, Mahmoud B.
    Dakour-Aridi, Hanaa
    Wang, Grace J.
    Kashyap, Vikram S.
    Motaganahalli, Raghu L.
    Eldrup-Jorgensen, Jens
    Cronenwett, Jack L.
    Schermerhorn, Marc L.
    [J]. JOURNAL OF VASCULAR SURGERY, 2019, 69 (01) : 92 - +
  • [9] The benefits of combined anti-platelet treatment in carotid artery stenting
    McKevitt, FM
    Randall, MS
    Cleveland, TJ
    Gaines, PA
    Tan, KT
    Venables, GS
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2005, 29 (05) : 522 - 527
  • [10] Ischemic stroke subtypes - A population-based study of incidence and risk factors
    Petty, GW
    Brown, RD
    Whisnant, JP
    Sicks, JD
    O'Fallon, WM
    Wiebers, DO
    [J]. STROKE, 1999, 30 (12) : 2513 - 2516